- IBDEI271 ; ; 04-FEB-2020
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.3,35030,1,4,0)
- ;;=4^G81.92
- ;;^UTILITY(U,$J,358.3,35030,2)
- ;;=^5004122
- ;;^UTILITY(U,$J,358.3,35031,0)
- ;;=G81.94^^137^1792^7
- ;;^UTILITY(U,$J,358.3,35031,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,35031,1,3,0)
- ;;=3^Hemiplegia,Unspec Affecting Left Nondominant Side
- ;;^UTILITY(U,$J,358.3,35031,1,4,0)
- ;;=4^G81.94
- ;;^UTILITY(U,$J,358.3,35031,2)
- ;;=^5004124
- ;;^UTILITY(U,$J,358.3,35032,0)
- ;;=G81.91^^137^1792^8
- ;;^UTILITY(U,$J,358.3,35032,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,35032,1,3,0)
- ;;=3^Hemiplegia,Unspec Affecting Right Dominant Side
- ;;^UTILITY(U,$J,358.3,35032,1,4,0)
- ;;=4^G81.91
- ;;^UTILITY(U,$J,358.3,35032,2)
- ;;=^5004121
- ;;^UTILITY(U,$J,358.3,35033,0)
- ;;=G81.93^^137^1792^9
- ;;^UTILITY(U,$J,358.3,35033,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,35033,1,3,0)
- ;;=3^Hemiplegia,Unspec Affecting Right Nondominant Side
- ;;^UTILITY(U,$J,358.3,35033,1,4,0)
- ;;=4^G81.93
- ;;^UTILITY(U,$J,358.3,35033,2)
- ;;=^5004123
- ;;^UTILITY(U,$J,358.3,35034,0)
- ;;=I69.942^^137^1792^22
- ;;^UTILITY(U,$J,358.3,35034,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,35034,1,3,0)
- ;;=3^Monoplg LL after Unsp Crbvasc Dis,Left Dominant Side
- ;;^UTILITY(U,$J,358.3,35034,1,4,0)
- ;;=4^I69.942
- ;;^UTILITY(U,$J,358.3,35034,2)
- ;;=^5133582
- ;;^UTILITY(U,$J,358.3,35035,0)
- ;;=I69.944^^137^1792^23
- ;;^UTILITY(U,$J,358.3,35035,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,35035,1,3,0)
- ;;=3^Monoplg LL after Unsp Crbvasc Dis,Left Nondominant Side
- ;;^UTILITY(U,$J,358.3,35035,1,4,0)
- ;;=4^I69.944
- ;;^UTILITY(U,$J,358.3,35035,2)
- ;;=^5133585
- ;;^UTILITY(U,$J,358.3,35036,0)
- ;;=I69.941^^137^1792^24
- ;;^UTILITY(U,$J,358.3,35036,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,35036,1,3,0)
- ;;=3^Monoplg LL after Unsp Crbvasc Dis,Right Dominant Side
- ;;^UTILITY(U,$J,358.3,35036,1,4,0)
- ;;=4^I69.941
- ;;^UTILITY(U,$J,358.3,35036,2)
- ;;=^5133581
- ;;^UTILITY(U,$J,358.3,35037,0)
- ;;=I69.943^^137^1792^25
- ;;^UTILITY(U,$J,358.3,35037,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,35037,1,3,0)
- ;;=3^Monoplg LL after Unsp Crbvasc Dis,Right Nondominant Side
- ;;^UTILITY(U,$J,358.3,35037,1,4,0)
- ;;=4^I69.943
- ;;^UTILITY(U,$J,358.3,35037,2)
- ;;=^5133584
- ;;^UTILITY(U,$J,358.3,35038,0)
- ;;=G35.^^137^1792^26
- ;;^UTILITY(U,$J,358.3,35038,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,35038,1,3,0)
- ;;=3^Multiple sclerosis
- ;;^UTILITY(U,$J,358.3,35038,1,4,0)
- ;;=4^G35.
- ;;^UTILITY(U,$J,358.3,35038,2)
- ;;=^79761
- ;;^UTILITY(U,$J,358.3,35039,0)
- ;;=G20.^^137^1792^27
- ;;^UTILITY(U,$J,358.3,35039,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,35039,1,3,0)
- ;;=3^Parkinson's disease
- ;;^UTILITY(U,$J,358.3,35039,1,4,0)
- ;;=4^G20.
- ;;^UTILITY(U,$J,358.3,35039,2)
- ;;=^5003770
- ;;^UTILITY(U,$J,358.3,35040,0)
- ;;=R56.9^^137^1792^3
- ;;^UTILITY(U,$J,358.3,35040,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,35040,1,3,0)
- ;;=3^Convulsions,Unspec
- ;;^UTILITY(U,$J,358.3,35040,1,4,0)
- ;;=4^R56.9
- ;;^UTILITY(U,$J,358.3,35040,2)
- ;;=^5019524
- ;;^UTILITY(U,$J,358.3,35041,0)
- ;;=S06.9X5S^^137^1792^14
- ;;^UTILITY(U,$J,358.3,35041,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,35041,1,3,0)
- ;;=3^Intcrn injury w LOC >24 hr w ret consc lev, sequela
- ;;^UTILITY(U,$J,358.3,35041,1,4,0)
- ;;=4^S06.9X5S
- ;;^UTILITY(U,$J,358.3,35041,2)
- ;;=^5021223
- ;;^UTILITY(U,$J,358.3,35042,0)
- ;;=S06.9X6S^^137^1792^15
- ;;^UTILITY(U,$J,358.3,35042,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,35042,1,3,0)
- ;;=3^Intcrn injury w LOC >24 hr w/o ret consc w surv, sqla
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI271 3835 printed Jan 18, 2025@03:24:14 Page 2
- IBDEI271 ; ; 04-FEB-2020
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- +2 if 'DIFQR(358.3)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.3,35030,1,4,0)
- +2 ;;=4^G81.92
- +3 ;;^UTILITY(U,$J,358.3,35030,2)
- +4 ;;=^5004122
- +5 ;;^UTILITY(U,$J,358.3,35031,0)
- +6 ;;=G81.94^^137^1792^7
- +7 ;;^UTILITY(U,$J,358.3,35031,1,0)
- +8 ;;=^358.31IA^4^2
- +9 ;;^UTILITY(U,$J,358.3,35031,1,3,0)
- +10 ;;=3^Hemiplegia,Unspec Affecting Left Nondominant Side
- +11 ;;^UTILITY(U,$J,358.3,35031,1,4,0)
- +12 ;;=4^G81.94
- +13 ;;^UTILITY(U,$J,358.3,35031,2)
- +14 ;;=^5004124
- +15 ;;^UTILITY(U,$J,358.3,35032,0)
- +16 ;;=G81.91^^137^1792^8
- +17 ;;^UTILITY(U,$J,358.3,35032,1,0)
- +18 ;;=^358.31IA^4^2
- +19 ;;^UTILITY(U,$J,358.3,35032,1,3,0)
- +20 ;;=3^Hemiplegia,Unspec Affecting Right Dominant Side
- +21 ;;^UTILITY(U,$J,358.3,35032,1,4,0)
- +22 ;;=4^G81.91
- +23 ;;^UTILITY(U,$J,358.3,35032,2)
- +24 ;;=^5004121
- +25 ;;^UTILITY(U,$J,358.3,35033,0)
- +26 ;;=G81.93^^137^1792^9
- +27 ;;^UTILITY(U,$J,358.3,35033,1,0)
- +28 ;;=^358.31IA^4^2
- +29 ;;^UTILITY(U,$J,358.3,35033,1,3,0)
- +30 ;;=3^Hemiplegia,Unspec Affecting Right Nondominant Side
- +31 ;;^UTILITY(U,$J,358.3,35033,1,4,0)
- +32 ;;=4^G81.93
- +33 ;;^UTILITY(U,$J,358.3,35033,2)
- +34 ;;=^5004123
- +35 ;;^UTILITY(U,$J,358.3,35034,0)
- +36 ;;=I69.942^^137^1792^22
- +37 ;;^UTILITY(U,$J,358.3,35034,1,0)
- +38 ;;=^358.31IA^4^2
- +39 ;;^UTILITY(U,$J,358.3,35034,1,3,0)
- +40 ;;=3^Monoplg LL after Unsp Crbvasc Dis,Left Dominant Side
- +41 ;;^UTILITY(U,$J,358.3,35034,1,4,0)
- +42 ;;=4^I69.942
- +43 ;;^UTILITY(U,$J,358.3,35034,2)
- +44 ;;=^5133582
- +45 ;;^UTILITY(U,$J,358.3,35035,0)
- +46 ;;=I69.944^^137^1792^23
- +47 ;;^UTILITY(U,$J,358.3,35035,1,0)
- +48 ;;=^358.31IA^4^2
- +49 ;;^UTILITY(U,$J,358.3,35035,1,3,0)
- +50 ;;=3^Monoplg LL after Unsp Crbvasc Dis,Left Nondominant Side
- +51 ;;^UTILITY(U,$J,358.3,35035,1,4,0)
- +52 ;;=4^I69.944
- +53 ;;^UTILITY(U,$J,358.3,35035,2)
- +54 ;;=^5133585
- +55 ;;^UTILITY(U,$J,358.3,35036,0)
- +56 ;;=I69.941^^137^1792^24
- +57 ;;^UTILITY(U,$J,358.3,35036,1,0)
- +58 ;;=^358.31IA^4^2
- +59 ;;^UTILITY(U,$J,358.3,35036,1,3,0)
- +60 ;;=3^Monoplg LL after Unsp Crbvasc Dis,Right Dominant Side
- +61 ;;^UTILITY(U,$J,358.3,35036,1,4,0)
- +62 ;;=4^I69.941
- +63 ;;^UTILITY(U,$J,358.3,35036,2)
- +64 ;;=^5133581
- +65 ;;^UTILITY(U,$J,358.3,35037,0)
- +66 ;;=I69.943^^137^1792^25
- +67 ;;^UTILITY(U,$J,358.3,35037,1,0)
- +68 ;;=^358.31IA^4^2
- +69 ;;^UTILITY(U,$J,358.3,35037,1,3,0)
- +70 ;;=3^Monoplg LL after Unsp Crbvasc Dis,Right Nondominant Side
- +71 ;;^UTILITY(U,$J,358.3,35037,1,4,0)
- +72 ;;=4^I69.943
- +73 ;;^UTILITY(U,$J,358.3,35037,2)
- +74 ;;=^5133584
- +75 ;;^UTILITY(U,$J,358.3,35038,0)
- +76 ;;=G35.^^137^1792^26
- +77 ;;^UTILITY(U,$J,358.3,35038,1,0)
- +78 ;;=^358.31IA^4^2
- +79 ;;^UTILITY(U,$J,358.3,35038,1,3,0)
- +80 ;;=3^Multiple sclerosis
- +81 ;;^UTILITY(U,$J,358.3,35038,1,4,0)
- +82 ;;=4^G35.
- +83 ;;^UTILITY(U,$J,358.3,35038,2)
- +84 ;;=^79761
- +85 ;;^UTILITY(U,$J,358.3,35039,0)
- +86 ;;=G20.^^137^1792^27
- +87 ;;^UTILITY(U,$J,358.3,35039,1,0)
- +88 ;;=^358.31IA^4^2
- +89 ;;^UTILITY(U,$J,358.3,35039,1,3,0)
- +90 ;;=3^Parkinson's disease
- +91 ;;^UTILITY(U,$J,358.3,35039,1,4,0)
- +92 ;;=4^G20.
- +93 ;;^UTILITY(U,$J,358.3,35039,2)
- +94 ;;=^5003770
- +95 ;;^UTILITY(U,$J,358.3,35040,0)
- +96 ;;=R56.9^^137^1792^3
- +97 ;;^UTILITY(U,$J,358.3,35040,1,0)
- +98 ;;=^358.31IA^4^2
- +99 ;;^UTILITY(U,$J,358.3,35040,1,3,0)
- +100 ;;=3^Convulsions,Unspec
- +101 ;;^UTILITY(U,$J,358.3,35040,1,4,0)
- +102 ;;=4^R56.9
- +103 ;;^UTILITY(U,$J,358.3,35040,2)
- +104 ;;=^5019524
- +105 ;;^UTILITY(U,$J,358.3,35041,0)
- +106 ;;=S06.9X5S^^137^1792^14
- +107 ;;^UTILITY(U,$J,358.3,35041,1,0)
- +108 ;;=^358.31IA^4^2
- +109 ;;^UTILITY(U,$J,358.3,35041,1,3,0)
- +110 ;;=3^Intcrn injury w LOC >24 hr w ret consc lev, sequela
- +111 ;;^UTILITY(U,$J,358.3,35041,1,4,0)
- +112 ;;=4^S06.9X5S
- +113 ;;^UTILITY(U,$J,358.3,35041,2)
- +114 ;;=^5021223
- +115 ;;^UTILITY(U,$J,358.3,35042,0)
- +116 ;;=S06.9X6S^^137^1792^15
- +117 ;;^UTILITY(U,$J,358.3,35042,1,0)
- +118 ;;=^358.31IA^4^2
- +119 ;;^UTILITY(U,$J,358.3,35042,1,3,0)
- +120 ;;=3^Intcrn injury w LOC >24 hr w/o ret consc w surv, sqla